Program & Downloads
Click here to download the program
Read articles from Liver International
Click here to view the speakers list
CONGRESS 2014
-
08:30
Introduction: Treatment of hepatitis C: soon the end of the road ?
-
Patrick MARCELLIN (France)
Download
-
08:45 - 09:15
State of the art lecture and Award
Chairman:
Tarik ASSELAH (France)
-
08:45
ANRS: perspectives for basic research in viral hepatitis
- Jean-François DELFRAISSY (France)
Download
-
09:15 - 10:30
How to optimize current therapy of G1 patients
Chairs :
Ira JACOBSON (USA) Masao OMATA (Japan)
-
09:15
Personalized treatment with telaprevir
- Graham FOSTER (UK)
Download
-
09:30
Personalized treatment with boceprevir
- Marc BOURLIERE (France)
Download
-
09:45
Is there still a role for PEG IFN+RBV therapy?
- Lawrence SERFATY (France)
Download
- 10:00 Round table discussion
- 10:30 - 11:00 Coffee break
-
11:00 - 12:00
How to optimize current therapy of non G1 patients
Chairs :
Graham FOSTER (UK) Michael MANNS (Germany)
-
11:00
Genotype 2
- Adrian GADANO (Argentina)
Download
-
11:15
Genotype 3
- Stanislas POL (France)
Download
-
11:30
Genotype 4
- Tarik ASSELAH (France)
Download
- 11:45 Round table discussion
-
12:00 - 12:30
State of the art lecture and Award
Chairman:
Patrick MARCELLIN (France)
-
12:00
Milestones in viral hepatitis
- Christian TREPO (France)
Download
-
12:30 - 14:30 Interactive luncheons Room 1
The long term impact of treatment on the outcome of liver disease?
Chairs: Michael FRIED (USA) Stefan ZEUZEM (Germany)
Room 2
First line therapy: interferon or analogues?
Chairs: Massimo COLOMBO (Italy) Teerha PIRATVISUTH (Thailand)
Room 3
Clinical applications of HBsAg quantification
Chairs: Henry CHAN (Hong Kong) Maurizia BRUNETTO (Italy)
Room 4
Staging of fibrosis: liver biopsy or indirect markers?
Chairs: Sam LEE (Canada) Victor DE LEDINGHEN (France)
Room 5
Treatment of HCV cirrhosis and transplanted patients
Chairs: Didier SAMUEL (France) Dominique VALLA (France)
Room 7
Interféron ou analogue ? (French speaking luncheon)
Chairs: Jean-Pierre ZARSKI (France) Philippe SOGNI (France)
Room 8
Faut-il traiter les immunotolérants et les porteurs inactifs ? (French speaking luncheon)
Chairs: Nathalie BOYER (France)
Download Jean-François David CADRANEL (France)
Download Mustapha BENAZZOUZ (Morocco)
Download
-
14:30 -15:45
Special populations
Chairs :
Sam LEE (Canada) François DURAND (France)
-
14:30
Patients with cirrhosis
- Savino BRUNO (Italy)
Download
-
14:45
Transplant patients
- Didier SAMUEL (France)
Download
-
15:00
HIV co-infected patients
- Douglas DIETERICH (USA)
Download
- 15:15 Round table discussion
- 15:45 - 16:00 Coffee break
-
16:00 - 17:15
New therapeutic strategies
Chairs :
David NELSON (USA) Stefan ZEUZEM (Germany)
-
16:00
Advantages of 2nd generation triple therapy
- Tarik ASSELAH (France)
Download
-
16:15
Protease, polymerase and NS5A inhibitors: what will be the wining combination?
- Raymond SCHINAZI (USA)
Download
-
16:30
Do we still need ribavirin?
- Mark SULKOWSKI (USA)
Download
- 16:45 Round table discussion
-
17:15
Controversy: F1/F2 patients: treat or wait?
Chairs :
Eugene SCHIFF (USA) Robert FLISIAK (Poland)
-
17:15
Treat now
- Yves BENHAMOU (France)
Download
-
17:30
Still wait
- Mitchell SHIFFMAN (USA)
Download
- 17:45 Conclusion - Patrick MARCELLIN (France)
- 18:00 Ajournement
- 19:30 Congress dinner
-
08:30
Introduction: HBV: Who, when and how to treat?
Chairman:
Patrick MARCELLIN (France)Download
-
08:40 - 10:00
The control of HBV related liver disease
Chairs :
Henry CHAN (Hong Kong) Fabien ZOULIM (France)
-
08:40
Regression of fibrosis. Is cirrhosis reversible?
- Antonio CRAXI (Italy)
Download
-
08:55
Are non-invasive markers of fibrosis reliable?
- Laurent CASTERA (France)
Download
-
09:10
HBsAg quantitation : useful for staging the liver disease?
- Maurizia BRUNETTO (Italy)
Download
-
09:25
HBsAg quantitation : useful for the indication and follow-up of therapy ?
- Michelle MARTINOT-PEIGNOUX (France)
Download
- 09:40 Round table discussion
- 10:00 - 10:30 Coffee break
-
10:30 - 11:30
Optimal therapy of HBeAg-positive chronic hepatitis B
Chairs :
Jidong JIA (China) Michael FRIED (USA)
-
10:30
Why do I treat my patient with a NUC?
- Maria BUTI (Spain)
Download
-
10:45
Why do I treat my patient with pegylated IFN?
- Jia-Horng KAO (Taiwan)
Download
- 11:00 Round table discussion
-
11:30 - 12:30
Optimal therapy of HBeAg-negative chronic hepatitis B
Chairs :
Seng Gee LIM (Singapore) Feruccio BONINO (Italy)
-
11:30
Why do I treat my patient with a NUC?
- Pietro LAMPERTICO (Italy)
Download
-
11:45
Why do I treat my patient with pegylated IFN?
- Georgios PAPATHEODORIDIS (Greece)
Download
- 12:00 Round table discussion
-
12:30 - 14:30 Interactive luncheons Room 1
How to optimize treatment in G1 naive patients?
Chairs: Antonio CRAXI (Italy) Vlad RATZIU (France)
Room 2
Resistance to DAAs: is this a real issue?
Chairs: Raymond SCHINAZI (USA) Philippe MATHURIN (France)
Room 3
How to manage relapsers and non-responders to PEG IFN + RBV therapy?
Chairs: Peter FERENCI (Austria)
Download Andrzej HORBAN (Poland) Konstantin ZHDANOV (Russia)
Room 4
Triple therapy with telaprevir or boceprevir: management of side effects
Chairs: Rafael ESTEBAN (Spain) Markus PECK RADOSAVLJEVIC (Austria)
Room 5
Future therapeutic strategies with direct acting antivirals
Chairs: Yves BENHAMOU (France) Massimo LEVRERO (France)
Room 7
Traitement des patients rechuteurs et non-répondeurs (French speaking luncheon)
Chairs: Christophe HEZODE (France) Jean-Pierre BRONOWICKI (France)
Room 8
Comment optimiser le traitement des malades naïfs ? (French speaking luncheon)
Chairs: Daniel DHUMEAUX (France) Mihai VOICULESCU (Romania)
Download
-
14:30 - 16:30
New therapeutic perspectives
Chairs :
Mario RIZZETTO (Italy) George LAU (Hong Kong)
-
14:30
New interferons and immunomodulators
- Jake LIANG (USA)
Download
-
14:45
Impact of HBV therapy on the incidence of hepatocellular carcinoma
- Massimo COLOMBO (Italy)
Download
-
15:00
When to stop NUCs?
- Rafael ESTEBAN (Spain)
Download
- 15:15 Round table discussion
-
15:45
Conclusion: tomorrow and after tomorrow?
-
Patrick MARCELLIN (France)
Download
- 16:00 Ajournement